Coronavirus: Commission approves contract with Moderna to ensure access to a potential vaccine
The European Commission yesterday approved a sixth contract under the EU Vaccines Strategy, this time with the pharmaceutical company Moderna. The contract provides for the initial purchase of 80 million doses on behalf of all EU Member States, plus an option to request up to a further 80 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19.
The contract with Moderna will enlarge the already broad portfolio of vaccines to be produced in Europe, including the contracts signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNTech-Pfizer and the contract approved with CureVac. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective. Member States can also decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.
President of the European Commission, Ursula von der Leyen, said:
“I'm very happy to announce today's agreement with the company Moderna to purchase up to 160 million doses of their future vaccine. This is our sixth contract with a vaccine producer, and we are working on yet another one. We are setting up one of the most comprehensive COVID-19 vaccine portfolios in the world, providing Europeans access to the most promising future vaccines under development so far. A safe and effective vaccine can help us end the pandemic, and return gradually to normal life.”
Stella Kyriakides, Commissioner for Health and Food Safety, said:
“Today's agreement with Moderna is yet another important milestone of our EU Vaccines Strategy. I am happy that we have now concluded six vaccine agreements so far. This is a clear demonstration of the European Health Union in action: a European Union that delivers tangible results for its citizens and a blueprint for our cooperation in the area of health in the future. A safe and effective vaccine is more important than ever in helping to restore normality and overcome this pandemic. No one is safe until everyone is safe.”
Moderna is a U.S. based company pioneering the development of a new class of vaccines based on messenger RNA (mRNA) transported into cells by lipid nanoparticles. The vaccine platform has been developed over the last decade. The basic principle is the use of this molecule as a data carrier, with the help of which the body itself can make proteins and trigger lasting immunity to COVID-19.
The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, and its production capacity in Europe to supply the whole of the EU.
Latest News from
Syrian foreign affairs minister added to EU sanctions list18/01/2021 16:33:00
The Council recently (15 January 2021) decided to add Faisal Mekdad to the list of persons subject to EU restrictive measures on Syria, in light of his recent appointment as Minister of Foreign Affairs.
Statement by President von der Leyen at the joint press conference with Prime Minister Costa on the occasion of the College visit to the Portuguese Presidency18/01/2021 15:25:00
Statement given recently (15 January 2021) by President von der Leyen at the joint press conference with Prime Minister Costa on the occasion of the College visit to the Portuguese Presidency.
Statement from the President of the European Commission following the detention of Alexei Navalny yesterday in Moscow18/01/2021 14:33:00
Statement given by President of the European Commission following the detention of Alexei Navalny yesterday in Moscow.
Commission and Portuguese Presidency announce Social Summit in Porto18/01/2021 13:25:00
Portuguese Prime Minister António Costa and European Commission President Ursula von der Leyen have invited EU Heads of State or Government, EU institutions, social partners and other key stakeholders to a Social Summit in Porto on 7 May 2021.
Coming up in plenary: vaccines, EU-US relations and Portuguese presidency18/01/2021 11:33:00
Covid-19 vaccines in the EU, relations with the US and the priorities of the new Council presidency will be discussed at the first plenary session of 2021.
European Citizens' Initiative: European Commission replies to ‘Minority Safepack' initiative18/01/2021 09:10:00
The European Commission responded to the European Citizens' Initiative ‘Minority Safepack – one million signatures for diversity in Europe', the fifth successful Initiative supported by over 1 million citizens across the EU.
Creative Europe: 30 years of support to European films and cultural and creative media works15/01/2021 15:25:00
The MEDIA strand of the EU programme Creative Europe, designed to support European film and audiovisual industries, is celebrating its 30th anniversary in 2021.
EIB and European Investment Advisory Hub support Thüringer Aufbaubank in delivering targeted advisory support to municipalities15/01/2021 13:25:00
The European Investment Bank (EIB) and the Thuringian Development Bank, Thüringer Aufbaubank (TAB), yesterday signed a grant agreement funded by the European Investment Advisory Hub.
EU files WTO panel request against illegal export restrictions by Indonesia on raw materials for stainless steel15/01/2021 12:38:00
The EU yesterday requested the establishment of a panel at the World Trade Organization (WTO) to seek the elimination of unlawful export restrictions imposed by Indonesia on raw materials necessary for the production of stainless steel, notably nickel ore and iron ore.